Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
Close Ad
SENSEX NIFTY
Samrat Pharmachem Company Background :- Pharmaceuticals, Company Background of Samrat Pharmachem - BSE: 530125, NSE: N.A
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > COMPANY BACKGROUND - Samrat Pharmachem

Samrat Pharmachem

BSE: 530125|ISIN: INE103E01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 18, 09:45
118.90
3.75 (3.26%)
VOLUME 145
Samrat Pharmachem is not listed on NSE
Company Background - Samrat Pharmachem
Industry Name Pharmaceuticals
House Name Not Applicable
Collaborative Country Name N.A.
Joint Sector Name N.A.
Year Of Incorporation 1992
Year Of Commercial Production N.A.
Regd. Office
Address Plot No A2/3445,, GIDC,
District Ankleshwar
State Gujarat
Pin Code 393002
Tel. No. 02646-220774,02646-251291
Fax No. 02646-251291
Email : samrat@bom4.vsnl.net.in Internet : http://www.samratpharmachem.com
Auditors
Shah & Savla LLP
Company Status
 N.A.
Registrars
Name Link Intime India Pvt. Ltd.
Address C 101, 247 Park,, L.B.S. Marg, Vikhroli (West), Mumbai - 400083, Maharashtra
Tel. No. : 022-49186270, 49186200 Fax No. : 022-49186060, 49186195
Email : rnt.helpdesk@linkintime.co.in Internet : http://www.linkintime.co.in
Source : Dion Global Solutions Limited
Quick Links for samratpharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.